Davenport Brings Legal, Biotech Savvy to NCSE Board

The newest member of North Carolina’s Southeast Commission’s board of directors brings a rich professional background to the organization’s leadership. Fred Davenport, who was appointed to the board last year by then-Governor Mike Easley, is a prominent attorney with a decades-long record of accomplishments in business law, as well as unique high-level executive experience with one of the region’s premiere life science companies. “Fred has an excellent business background and will add a lot to our board,” says Jane W. Smith, chairman of North Carolina’s Southeast Commission.

Mr. Davenport is currently an attorney with the firm of Murchison, Taylor & Gibson, PLLC, in downtown Wilmington. His legal expertise includes life sciences, corporate law and taxation, and mergers and acquisitions. From 2002 through 2006, he was president of Pharmaceutical Product Development, Inc. (“PPD”), a leading contract research organization with offices in 33 countries and 10,500-person workforce worldwide. Mr. Davenport had joined PPD’s staff in 1996 as general counsel. “Fred’s expertise in biotechnology brings a valuable perspective in an emerging area that we’re excited about,” Ms. Smith says.

Mr. Davenport holds a B.A. degree from the University of North Carolina at Chapel Hill and is also an alumnus of UNC’s law and graduate business schools.  He has been a member of the North Carolina Bar since 1977. Mr. Davenport also served on the faculty of the Cameron School of Business at the University of North Carolina at Wilmington from 1982 until 1991, attaining the post of associate professor.